Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67836-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- OXCT1 antibody
- Antibody type
- Monoclonal
- Description
- OXCT1 antibody (Cat. #67836-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat, pig, rabbit and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat, Porcine, Rabbit
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1G1B9
- Vial size
- 20ul, 150ul
Submitted references β-hydroxybutyrate serves as a regulator in ketone body metabolism through lysine β-hydroxybutyrylation.
OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth.
Putative Role of Fatty Acid Metabolic Therapy Using Ketogenic Diet and HIF-1α Inhibition in Hepatocellular Carcinoma: Evidence from an In Vitro Study.
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway.
Imaging phenotype reveals that disulfirams induce protein insolubility in the mitochondrial matrix.
Fang J, Hu Z, Luo T, Chen S, Li J, Yang H, Sheng X, Zhang X, Zhang Z, Xie C
The Journal of biological chemistry 2025 May;301(5):108475
The Journal of biological chemistry 2025 May;301(5):108475
OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth.
Guo D, Yu Q, Tong Y, Qian X, Meng Y, Ye F, Jiang X, Wu L, Yang Q, Li S, Li M, Wu Q, Xiao L, He X, Zhu R, Liu G, Nie D, Luo S, Ma L, Jin RA, Liu Z, Liang X, Yan D, Lu Z
Molecular cell 2025 Feb 20;85(4):843-856.e6
Molecular cell 2025 Feb 20;85(4):843-856.e6
Putative Role of Fatty Acid Metabolic Therapy Using Ketogenic Diet and HIF-1α Inhibition in Hepatocellular Carcinoma: Evidence from an In Vitro Study.
Kimura N, Kitajima Y, Higure K, Matsufuji S, Ikeda S, Furukawa S, Yukimoto K, Tanaka T, Noshiro H
International journal of molecular sciences 2025 Dec 5;26(24)
International journal of molecular sciences 2025 Dec 5;26(24)
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway.
Kato Y, Matsumoto M, Takano N, Hirao M, Matsuda K, Tozuka T, Onda N, Nakamichi S, Takeuchi S, Miyanaga A, Noro R, Gemma A, Seike M
Cancer medicine 2024 Jun;13(12):e7393
Cancer medicine 2024 Jun;13(12):e7393
Imaging phenotype reveals that disulfirams induce protein insolubility in the mitochondrial matrix.
Ohno K, Murakami H, Ogo N, Asai A
Scientific reports 2024 Dec 28;14(1):31401
Scientific reports 2024 Dec 28;14(1):31401
No comments: Submit comment
No validations: Submit validation data